Congress Unplugged presents Magali Haas, Partner, Janssen R&D Innovation at Johnson & Johnson. Join Haas on a brief dive into culture, values, data and potential factors in a lifetime of brain health."
Magali Haas earned her Bachelor of Science in bioengineering from the University of Pennsylvania, a Master of Science in biomedical engineering degree from Rutgers University, New Jersey, and her medical degree and doctorate in neuroscience from Albert Einstein College of Medicine, New York, under the National Institutes of Health Medical Scientist Training Program. She received the Julius Marmur Research Award from Albert Einstein College of Medicine, in 1997. Dr. Haas joined the Johnson & Johnson organization in 2001 and has gained extensive end-to-end development experience across the various leadership roles she has assumed in medical marketing, full clinical development, early development, translational and biomarker sciences in Psychiatry and Neurology. She oversaw the filing and approval of an antipsychotic for pediatric indications in autism, schizophrenia, and bipolar disorder as well as the clinical Phase 2/3 programs for a novel anticonvulsant drug in epilepsy, migraine and neuropathic pain. She has published over 20 peer-reviewed articles, holds several patents and authored a recent Chapter on Pediatric Trial Methodology. She currently Heads the Department of Integrative Solutions which develops Stratified Medicine strategies and Companion Diagnostics & Solutions for AD, Mood, Schizophrenia and Pain.